Medical Ikkou Group Co.,Ltd. (TYO:3353)
2,966.00
+5.00 (0.17%)
Jan 23, 2026, 1:50 PM JST
Medical Ikkou Group Balance Sheet
Financials in millions JPY. Fiscal year is March - February.
Millions JPY. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '25 Nov 30, 2025 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 | Feb '21 Feb 28, 2021 | 2016 - 2020 |
Cash & Equivalents | 7,384 | 6,768 | 7,700 | 6,443 | 7,992 | 7,003 | Upgrade |
Cash & Short-Term Investments | 7,384 | 6,768 | 7,700 | 6,443 | 7,992 | 7,003 | Upgrade |
Cash Growth | -15.66% | -12.10% | 19.51% | -19.38% | 14.12% | 22.99% | Upgrade |
Receivables | 8,238 | 7,479 | 6,058 | 5,007 | 4,888 | 4,735 | Upgrade |
Inventory | 2,410 | 2,215 | 1,752 | 1,228 | 1,214 | 1,095 | Upgrade |
Other Current Assets | 1,699 | 1,503 | 1,212 | 561 | 483 | 821 | Upgrade |
Total Current Assets | 19,731 | 17,965 | 16,722 | 13,239 | 14,577 | 13,654 | Upgrade |
Property, Plant & Equipment | 10,927 | 10,042 | 9,116 | 9,587 | 9,864 | 10,114 | Upgrade |
Long-Term Investments | 5,990 | 4,714 | 4,495 | 2,836 | 2,519 | 2,430 | Upgrade |
Goodwill | 805 | 816 | 692 | 1,296 | 1,536 | 1,780 | Upgrade |
Other Intangible Assets | 174 | 173 | 168 | 182 | 177 | 153 | Upgrade |
Long-Term Deferred Tax Assets | - | 521 | 464 | 363 | 419 | 422 | Upgrade |
Other Long-Term Assets | 2 | - | 2 | 2 | 2 | 2 | Upgrade |
Total Assets | 37,629 | 34,231 | 31,659 | 27,505 | 29,094 | 28,555 | Upgrade |
Accounts Payable | 6,800 | 6,072 | 5,231 | 3,438 | 3,481 | 3,491 | Upgrade |
Accrued Expenses | 26 | 266 | 276 | 222 | 226 | 221 | Upgrade |
Short-Term Debt | 1,480 | 1,180 | 1,345 | 170 | 170 | 740 | Upgrade |
Current Portion of Long-Term Debt | 2,325 | 2,609 | 2,349 | 2,694 | 3,562 | 3,251 | Upgrade |
Current Income Taxes Payable | 293 | 535 | 380 | 189 | 279 | 359 | Upgrade |
Other Current Liabilities | 1,965 | 1,006 | 823 | 741 | 698 | 1,036 | Upgrade |
Total Current Liabilities | 12,889 | 11,668 | 10,404 | 7,454 | 8,416 | 9,098 | Upgrade |
Long-Term Debt | 7,143 | 6,052 | 5,717 | 6,062 | 7,372 | 7,611 | Upgrade |
Long-Term Leases | 156 | 175 | 166 | 189 | 207 | 245 | Upgrade |
Pension & Post-Retirement Benefits | 1,190 | 1,100 | 1,016 | 802 | 761 | 696 | Upgrade |
Other Long-Term Liabilities | 785 | 525 | 516 | 392 | 411 | 420 | Upgrade |
Total Liabilities | 22,163 | 19,520 | 17,819 | 14,899 | 17,167 | 18,070 | Upgrade |
Common Stock | 917 | 917 | 917 | 917 | 917 | 917 | Upgrade |
Additional Paid-In Capital | 1,064 | 1,085 | 1,081 | 1,081 | 1,080 | 853 | Upgrade |
Retained Earnings | 12,468 | 12,391 | 11,447 | 10,557 | 9,948 | 9,247 | Upgrade |
Treasury Stock | -7 | -531 | -537 | -539 | -541 | -541 | Upgrade |
Comprehensive Income & Other | 375 | 235 | 332 | 32 | -21 | 9 | Upgrade |
Total Common Equity | 14,817 | 14,097 | 13,240 | 12,048 | 11,383 | 10,485 | Upgrade |
Minority Interest | 649 | 614 | 600 | 558 | 544 | - | Upgrade |
Shareholders' Equity | 15,466 | 14,711 | 13,840 | 12,606 | 11,927 | 10,485 | Upgrade |
Total Liabilities & Equity | 37,629 | 34,231 | 31,659 | 27,505 | 29,094 | 28,555 | Upgrade |
Total Debt | 11,104 | 10,016 | 9,577 | 9,115 | 11,311 | 11,847 | Upgrade |
Net Cash (Debt) | -3,720 | -3,248 | -1,877 | -2,672 | -3,319 | -4,844 | Upgrade |
Net Cash Per Share | -988.53 | -863.77 | -499.51 | -711.27 | -883.64 | -1283.89 | Upgrade |
Filing Date Shares Outstanding | 3.77 | 3.76 | 3.76 | 3.76 | 3.76 | 3.76 | Upgrade |
Total Common Shares Outstanding | 3.77 | 3.76 | 3.76 | 3.76 | 3.76 | 3.76 | Upgrade |
Working Capital | 6,842 | 6,297 | 6,318 | 5,785 | 6,161 | 4,556 | Upgrade |
Book Value Per Share | 3934.54 | 3747.48 | 3523.03 | 3206.79 | 3030.60 | 2791.41 | Upgrade |
Tangible Book Value | 13,838 | 13,108 | 12,380 | 10,570 | 9,670 | 8,552 | Upgrade |
Tangible Book Value Per Share | 3674.57 | 3484.57 | 3294.19 | 2813.39 | 2574.53 | 2276.79 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.